Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 25,286 followers.

RT @JNilsson_lab: This was an interesting case report. It is not inconceivable that T cells recruited to metastatic uveal melanoma by teben…

27 May 2023

Reply Repost Favourite

RT @JNilsson_lab: This was an interesting case report. It is not inconceivable that T cells recruited to metastatic uveal melanoma by teben…

20 May 2023

Reply Repost Favourite

This was an interesting case report. It is not inconceivable that T cells recruited to metastatic uveal melanoma by tebentafusp would be inactivated by immune checkpoints and therefore respond to ICI https://t.co/GId95lZJ41

20 May 2023

Reply Repost Favourite

Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report https://t.co/HvbSiYDngk

20 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.